Synthesis Media LLC Press Releases

• Published on August 26, 2025 - 13:00 GMT

  Bioxytech Retina Announces Strategic Investment from Topcon Healthcare

  OAKLAND, CA, UNITED STATES, August 26, 2025 /⁨EINPresswire.com⁩/ -- Bioxytech Retina today announced a strategic investment by Topcon Healthcare, Inc., a global leader in ophthalmic imaging devices and digital health solutions. The investment represents a …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 9, 2025 - 12:00 GMT

  

  Alessa Therapeutics Announces First Patient Enrolled in Enolen Study for Localized Drug Delivery for Prostate Cancer

  SAN CARLOS, CA, UNITED STATES, January 9, 2025 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 16, 2024 - 12:00 GMT

  

  Alessa Therapeutics Appoints Cam Gallagher as President & Chief Executive Officer

  Founding CEO Dr. Pamela Munster, M.D., will transition to Chief Scientific Officer and continue to serve on the Board of Directors SAN CARLOS, CA, UNITED STATES, December 16, 2024 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, a clinical-stage drug …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on December 12, 2024 - 14:36 GMT

  

  Alessa Therapeutics Announces Closing $15M Seed Financing

  SAN CARLOS, CA, UNITED STATES, December 12, 2024 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery technology for the early interception of cancer …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on July 5, 2022 - 13:00 GMT

  

  Alessa Therapeutics Announces Dr. Pamela Munster appointed Chief Executive Officer

  Dr. Munster is a medical oncologist at UCSF and the founder of Alessa Therapeutics SAN CARLOS, CA, UNITED STATES, July 5, 2022 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 23, 2022 - 14:00 GMT

  

  Alessa Therapeutics Announces First Patient Enrollment in Biolen®+RT Study with National Cancer Institute

  Biolen+RT (NCT 04943536) is a Phase 1 clinical study conducted in collaboration with the Radiation Oncology Branch of the NCI SAN CARLOS, CA, UNITED STATES, February 23, 2022 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on October 11, 2021 - 13:00 GMT

  

  Alessa Therapeutics Announces Research Collaboration with Janssen

  SAN CARLOS, CA, USA, October 11, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug development company developing implantable drug delivery systems focused on sustained delivery of drugs to solid organ tumors, announced that it …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on June 7, 2021 - 12:00 GMT

  

  Alessa Therapeutics Announces IND Clearance for a Study in Collaboration with the National Cancer Institute

  First patient enrollment anticipated in Q3 2021 for Phase 1 clinical study of Biolen in conjunction with radiation therapy in localized prostate cancer SAN CARLOS, CALIFORNIA, UNITED STATES, June 7, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on March 17, 2021 - 20:00 GMT

  

  Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for New Therapy for Prostate Cancer

  Wollongong Private Hospital in NSW enrolls first patient in trial of new drug-delivery technology SAN CARLOS, CALIFORNIA, UNITED STATES, March 17, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a privately held drug development company developing …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on October 13, 2020 - 13:00 GMT

  

  Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer

  SAN CARLOS, CALIFORNIA, US, October 13, 2020 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, …

  Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...